82 results
Page 2 of 5
8-K
EX-99.1
pjy8 kjtxizfwq81x
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.1
kj3 oau4c
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
EX-10.12
e4jbodd5iwtrdf0a
17 Aug 09
Other Events
12:00am
8-K
EX-10.14
l28gs 2a83n4lte1b
17 Aug 09
Other Events
12:00am
8-K
EX-99.1
vw3ark cb28s
28 Apr 09
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
424B5
qluonj
17 Nov 06
Prospectus supplement for primary offering
12:00am